other material
confidence high
sentiment neutral
materiality 0.70
Bioxytran amends preferred stock conversion rights, grants CEO 6M preferred shares
BIOXYTRAN, INC
- Amendment requires both Board and majority of Preferred holders to approve any conversion of Convertible Preferred Stock into common shares.
- Filing effective Feb 18, 2026 with Nevada Secretary of State.
- CEO David Platt granted 6,000,000 shares of Convertible Preferred Stock as performance-based equity award.
- Grant tied to execution of first commercial distribution agreement and capital funding initiatives.
- Aligns executive incentives with commercialization and capital formation.